Details
Product Name in the RMS: Certican
MR Number: SE/H/0356/004
Date of outcome: 02.12.2003
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
New Active Substance Additional Strength/Form Full Dossier Chemical Substance Prescription Only |
Active Substances |
everolimus 1 mg |
Form | Tablet |
MA Holder in the RMS |
Novartis Sverige AB Sweden |
RMS | Sweden |
Date of last change | 26.11.2020 |
ATC-Code |
L04AA18 Everolimus |
CMS Country | Domestic Product Name |
---|---|
Austria | Certican 1 mg - Tabletten |
Belgium | |
Bulgaria | Certican |
Croatia | |
Cyprus | |
Czech Republic | |
Denmark | |
Estonia | |
Finland | |
France | |
Germany | |
Greece | |
Hungary | |
Iceland | |
Ireland | |
Italy | |
Latvia | |
Lithuania | Certican 1mg tabletÄ—s |
Luxembourg | |
Malta | |
Netherlands | |
Norway | |
Poland | |
Portugal | |
Romania | CERTICAN 1 g comprimate |
Slovak Republic | |
Slovenia | |
Spain | Certican 1 mg comprimidos |
United Kingdom |
Documents | |
---|---|
PAR: | http://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000416 (10.12.2014) |
PARSummary: | http://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000447 (09.01.2015) |
FinalSPC: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000447 (15.01.2014) |
FinalPL: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20030718000447 (15.01.2014) |